Markets
DroneShield’s run as the latest market darling made a hard stop last week after a colossal selldown in shares from its leadership. Investors may have lost faith for good.
In response to a question from Capital Brief, the treasurer argued the predicament facing reluctant suitor Cosette Pharmaceuticals was unlikely to be a common one.
The chief executive of the country's largest listed data centre pure play was in a combative mood despite facing a massive shareholder revolt.
